Federation des caisses Desjardins du Quebec’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5K Hold
400
﹤0.01% 2111
2026
Q1
$21.6K Hold
400
﹤0.01% 2083
2025
Q4
$22.4K Hold
400
﹤0.01% 2033
2025
Q3
$19.2K Hold
400
﹤0.01% 2056
2025
Q2
$16.2K Hold
400
﹤0.01% 1870
2025
Q1
$17.5K Hold
400
﹤0.01% 1771
2024
Q4
$17.2K Hold
400
﹤0.01% 1721
2024
Q3
$17.7K Hold
400
﹤0.01% 1705
2024
Q2
$15.9K Hold
400
﹤0.01% 1672
2024
Q1
$17.3K Hold
400
﹤0.01% 1681
2023
Q4
$16.6K Hold
400
﹤0.01% 1629
2023
Q3
$15.9K Hold
400
﹤0.01% 1641
2023
Q2
$16.4K Hold
400
﹤0.01% 1626
2023
Q1
$16.4K Hold
400
﹤0.01% 1632
2022
Q4
$16.4K Hold
400
﹤0.01% 1740
2022
Q3
$16.1K Hold
400
﹤0.01% 1794
2022
Q2
$16.8K Hold
400
﹤0.01% 1817
2022
Q1
$18.1K Sell
400
-110
-22% -$4.83K ﹤0.01% 1855
2021
Q4
$23.5K Hold
510
﹤0.01% 1786
2021
Q3
$24.2K Hold
510
﹤0.01% 1796
2021
Q2
$26.4K Hold
510
﹤0.01% 1784
2021
Q1
$25.7K Hold
510
﹤0.01% 1743
2020
Q4
$26.6K Hold
510
﹤0.01% 1670
2020
Q3
$22.2K Hold
510
﹤0.01% 1463
2020
Q2
$21.9K Hold
510
﹤0.01% 1423
2020
Q1
$18.4K Sell
510
-950
-65% -$40.5K ﹤0.01% 1507
2019
Q4
$66.7K Sell
1,460
-210
-13% -$8.32K ﹤0.01% 1434
2019
Q3
$59.4K Buy
1,670
+400
+31% +$14.9K ﹤0.01% 1430
2019
Q2
$50.6K Sell
1,270
-30
-2% -$1.18K ﹤0.01% 1483
2019
Q1
$54.1K Hold
1,300
﹤0.01% 1304
2018
Q4
$47.6K Hold
1,300
﹤0.01% 1298
2018
Q3
$63.1K Sell
1,300
-125
-9% -$5.92K ﹤0.01% 1288
2018
Q2
$61.3K Sell
1,425
-305
-18% -$12.8K ﹤0.01% 1304
2018
Q1
$72.4K Buy
1,730
+85
+5% +$3.7K ﹤0.01% 1239
2017
Q4
$71.6K Buy
1,645
+310
+23% +$13.2K ﹤0.01% 1254
2017
Q3
$56.8K Sell
1,335
-65
-5% -$2.76K ﹤0.01% 1289
2017
Q2
$60.2K Sell
1,400
-545
-28% -$23K ﹤0.01% 1342
2017
Q1
$81.4K Buy
+1,945
New +$79.3K ﹤0.01% 1065

Other funds holding XPH

Federation des caisses Desjardins du Quebec's XPH Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 400 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Federation des caisses Desjardins du Quebec first reported a position in XPH in Q1 2017 and has held it in 38 quarters since. The position peaked at $81.4K in Q1 2017. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 400 shares of State Street SPDR S&P Pharmaceuticals ETF worth $26.5K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2111 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2017 and has held it in 38 quarters since.
  • Federation des caisses Desjardins du Quebec's State Street SPDR S&P Pharmaceuticals ETF position peaked at $81.4K in Q1 2017.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.